G2 INFLAMMATION PTY LTD has a total of 32 patent applications. Its first patent ever was published in 2004. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and agriculture are TEVA BIOPHARMACEUTICALS USA INC, SELEXYS PHARMACEUTICALS CORP and IPROTEOS S L.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Australia | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Brazil | 2 | |
#6 | Canada | 2 | |
#7 | Israel | 2 | |
#8 | Japan | 2 | |
#9 | Republic of Korea | 2 | |
#10 | Mexico | 2 | |
#11 | United States | 2 | |
#12 | South Africa | 2 | |
#13 | Norway | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Agriculture | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Animal care | |
#6 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Mackay Charles Reay | 21 |
#2 | Whitfeld Peter | 11 |
#3 | Zahra David | 11 |
#4 | Mackay Charles | 7 |
#5 | David Zahra | 1 |
#6 | Reay Mackay Charles | 1 |
#7 | Charles Mackay | 1 |
#8 | Peter Whitfeld | 1 |
Publication | Filing date | Title |
---|---|---|
JP2012050451A | TRANSGENIC NON-HUMAN MAMMAL COMPRISING POLYNUCLEOTIDE ENCODING HUMAN OR HUMANIZED C5aR | |
WO2009103113A1 | HUMANIZED ANTI-C5aR ANTIBODIES | |
CN101506237A | Anti-c5ar antibodies with improved properties | |
CN101501073A | Method for producing antibodies |